Novel Leukemia Vaccine for High-Risk Patients
UC San Diego HealthResearchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia.